CONMED Corp (CNMD)
- Sector
- Health Care
- Last price
- $45.76
- As of
Kresmion compiles this page from CNMD's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
CONMED Corp (CNMD): 5 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-10-28.
See the full CNMD dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for CNMD on one page. Preview it with sample data, then open it live with a free account.
Preview the CNMD dossierActive events for CNMD
- high13F: large reduction
CITADEL ADVISORS LLC cut 88% of CNMD (2026Q2)
- high13F: large increase
CITADEL ADVISORS LLC added +172% to CNMD (2026Q2)
- high13F: large increase
MILLENNIUM MANAGEMENT LLC added +51% to CNMD (2026Q2)
- mediumEarnings above estimates
Q2-2026: Beat consensus by 21.8%, EPS $1.38 vs $1.1326 estimate
- high13F: large reduction
MILLENNIUM MANAGEMENT LLC cut 59% of CNMD (2026Q1)
FREE, NO ACCOUNT
Every event on CNMD, as it fires
You are seeing 5 of 9 events recorded on CNMD since 2026-05-29.
The five above landed across 3 days. The other 4 were recorded on 1 other days. 6 of the 9 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in CNMD (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| TWO SIGMA INVESTMENTS, LPCUSIP 207410101 · 2026Q2 | $23.9M | 0.02% | , |
| CITADEL ADVISORS LLCCUSIP 207410101 · 2026Q2 | $4.7M | 0.00% | , |
| MILLENNIUM MANAGEMENT LLCCUSIP 207410101 · 2026Q2 | $3.8M | 0.00% | , |
| Point72 Asset Management, L.P.CUSIP 207410101 · 2026Q2 | $2.3M | 0.00% | , |
| D. E. Shaw & Co., Inc.CUSIP 207410101 · 2026Q2 | $2.2M | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, CNMD
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
CNMD against its peers
CNMD's operating margin of 7.5% ranks in the 79th percentile of 25 Health Care sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-01-02.
| Metric | CNMD | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 1.4B USD | 764M USD | 79 | 25 |
| Gross margin | 54.6% | 68.3% | 36 | 17 |
| Operating margin | 7.5% | 0.4% | 79 | 25 |
| Net margin | 3.4% | -0.0% | 67 | 25 |
| Return on equity | 4.6% | -0.2% | 56 | 25 |
| P / E | 30.3x | 46.2x | 14 | 10 |
Peers (25): TNDM, PNTG, USPH, TDOC, STAA, GDRX, OMDA, PRCT, OMCL, NVCR, ALHC, IRMD, CERT, ATEC, AMN, HSTM, BVS, CSTL, XRAY, LMAT, WGS, SEM.D, INSP, PGNY, TALK.D. Fiscal periods ending between 2025-12-31 and 2026-01-02. Every figure is one full fiscal year read from one annual filing (CNMD: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow CNMD on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to CNMD for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.